Bupropion Hydrochloride Tablet, Film Coated, Extended Release
Product Images NDC 77771-145

This is a medication description for an extended-release tablet containing 150 mg of bupropion HC, USP. The usual dosage is one tablet per day as directed by a physician. The medication should be stored at a temperature between 15°C to 30°C (59°F to 86°F). The tablets are manufactured by ScieGen Pharmaceuticals and distributed by Radha Pharmaceuticals Inc. The medication should not be used in combination with Zyban or any other medicine that contains bupropion hydrochloride. This medication comes in a bottle of 30 tablets and should be dispensed with a medication guide by a pharmacist.*

This is a medication description for Bupropion Hydrochloride Extended-Release Tablets, USP (XL). Each tablet contains 150mg bupropion HCI, USP. The usual dosage is one tablet daily as directed by physician. The medication should be stored at 25°C (7°F) with excursions permitted to 15°C to 30°C (59°F to 86°F) [see USP Controlled Room Temperature]. It is distributed by Radha Pharmaceuticals and manufactured by ScieGen Pharmaceuticals. The medication should not be used in combination with Zyban or any other medicines that contain bupropion hydrochloride. There is a warning included for the pharmacists to dispense the accompanying Medication Guide to each patient. The product contains 500 tablets and is available by prescription only.*

Each extended-release tablet contains 150 mg of bupropion HCI, USP for treating depression and smoking cessation. The usual dosage is one tablet per day, or as advised by a physician. Storage should be at a room temperature of 25°C (77°F), with limited excursions allowed, according to USP Controlled Room Temperature guidelines. The medicine comes with a Medication Guide for patients, and usage in combination with Zyban or other medications containing bupropion hydrochloride is not advised. The medication is manufactured by ScieGen Pharmaceuticals and distributed in the USA by Radha Pharmaceuticals. This package contains 90 tablets.*

This is a medication information sheet for an extended-release tablet called Bupropion Hydrochloride. The tablet contains 300 mg of bupropion HC, USP, and is intended to be taken once daily or as directed by a physician. The usual dosage information can be found in the prescribing information. The tablet should be stored at room temperature, and the manufacturer is ScieGen Pharmaceuticals, Inc. The medication is distributed by Radha Pharmaceuticals, Inc. in Hauppauge, NY. The medication should not be used in combination with Zyban or any other medication containing bupropion hydrochloride. The accompanying medication guide should be dispensed to each patient by the pharmacist.*

This is a medication description for bupropion HCI, an extended-release tablet manufactured by ScieGen Pharmaceuticals and distributed by Radha Pharmaceuicals, Inc. Each tablet contains 300 mg of the medication and the usual dosage is one tablet daily as directed by a physician. It is important not to use this medication in combination with other drugs containing bupropion hydrochloride, including Zyban. Pharmacists should dispense the accompanying medication guide to each patient. The tablets should be stored at a controlled room temperature between 15°C to 30°C (59°F to 86°F).*

This is a description of a medication called Noc 77771-145-0 containing 300mg of bupropion HCI in an extended-release tablet form. The suggested dosage is one tablet a day or as advised by a physician. The medication must be stored at 25°C (77°F) with permitted excursions to 15°C and 30°C (59°F to 86°F). The text also contains a warning regarding Zyban or any other medicines containing bupropion hydrochloride. The medication guide should be dispensed with the medicine. It is distributed by Radha Pharmaceuticals Inc. and manufactured by ScieGen Pharmaceuticals Inc.*